OSCR

Network Pharmacology-Based Elucidation of Gu's Anshen Decoction in Modulating TNF Signaling to Ameliorate Insomnia.

Overview

Authors: Sanyuan Gu1, Jingyu Xu1
  1. Leshan Vocational and Technical College, Leshan, 614000, People’s Republic of China
Journal: Nature and science of sleep, volume 18, article 582222
Dates: received 20 November 2025; accepted 19 May 2026; published online 28 May 2026
Type: Research article · Language: English
License: CC BY-NC
Identifiers: DOI 10.2147/nss.s582222 · PMID 42233047 · PMCID PMC13225028 · OpenAlex W7162691355
Open access: gold, a free copy (OpenAlex)
Categories: rat (organism), sleep disorders (population), cellular / molecular (subfield)
Methods: Statistics, Graphs
Keywords: Gu’s Anshen decoction, insomnia, network pharmacology, TNF signaling pathway, neuroinflammation
Topic: Sleep and related disorders (Experimental and Cognitive Psychology, Psychology), according to OpenAlex
Citations: not cited yet (Europe PMC); 47 references in the paper

Abstract

Objective: To investigate the therapeutic mechanisms of Gu’s Anshen decoction (GAD) against insomnia (INS), focusing on the regulation of tumor necrosis factor (TNF)-mediated inflammatory pathways.

Methods: Bioactive compounds and potential targets of GAD were identified via network pharmacology and constructed herb–compound–target interaction network. INS-related targets derived from peripheral blood mononuclear cells in the Gene Expression Omnibus (GEO) database were intersected with GAD targets to establish a protein-protein interaction (PPI) network. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed to identify the key pathways. Experimental validation employed a para-chlorophenylalanine (PCPA)-induced INS rat model, integrating behavioral tests, histopathology, and inflammatory cytokine quantification.

Results: Network pharmacology revealed multi-target, multi-pathway actions of GAD against INS, with the TNF signaling pathway identified as a critical axis. Animal experiments demonstrated that GAD significantly improved sleep architecture in INS rats, reduced serum and hippocampal levels of TNF-α and interleukin-1β (IL-1β), and downregulated phosphorylated NF-κB p65 (p-p65) expression, indicating suppression of TNF-driven neuroinflammation.

Conclusion: GAD ameliorates INS in a rat model by inhibiting TNF-mediated inflammatory signaling, offering a potential mechanistic basis for its therapeutic use in INS management.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Other data links

Data Sharing Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 2 authors, 5 keywords, 47 references.

Cite

This paper

Gu, S., & Xu, J. (2026). Network Pharmacology-Based Elucidation of Gu's Anshen Decoction in Modulating TNF Signaling to Ameliorate Insomnia. Nature and science of sleep, 18, 582222. https://doi.org/10.2147/nss.s582222

BibTeX

@article{gu2026network,
author = {Gu, Sanyuan and Xu, Jingyu},
title = {{Network Pharmacology-Based Elucidation of Gu's Anshen Decoction in Modulating TNF Signaling to Ameliorate Insomnia}},
journal = {Nature and science of sleep},
year = {2026},
month = may,
volume = {18},
pages = {582222},
publisher = {Dove Press},
issn = {1179-1608},
doi = {10.2147/nss.s582222},
url = {https://doi.org/10.2147/nss.s582222},
pmid = {42233047},
pmcid = {PMC13225028}
}

RIS

TY - JOUR
AU - Gu, Sanyuan
AU - Xu, Jingyu
TI - Network Pharmacology-Based Elucidation of Gu's Anshen Decoction in Modulating TNF Signaling to Ameliorate Insomnia
T2 - Nature and science of sleep
J2 - Nat Sci Sleep
PY - 2026
DA - 2026/05/28
VL - 18
SP - 582222
SN - 1179-1608
PB - Dove Press
DO - 10.2147/nss.s582222
UR - https://doi.org/10.2147/nss.s582222
LA - en
ER -

CSL-JSON

{
"id": "10.2147/nss.s582222",
"type": "article-journal",
"title": "Network Pharmacology-Based Elucidation of Gu's Anshen Decoction in Modulating TNF Signaling to Ameliorate Insomnia",
"container-title": "Nature and science of sleep",
"author": [
{
"family": "Gu",
"given": "Sanyuan"
},
{
"family": "Xu",
"given": "Jingyu"
}
],
"container-title-short": "Nat Sci Sleep",
"volume": "18",
"page": "582222",
"DOI": "10.2147/nss.s582222",
"PMID": "42233047",
"PMCID": "PMC13225028",
"ISSN": "1179-1608",
"publisher": "Dove Press",
"URL": "https://doi.org/10.2147/nss.s582222",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
28
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s12906-025-05196-z
Integrating serum pharmacochemistry with network pharmacology and pharmacological validation to elucidate the mechanism of KaiXinSan in treating insomnia.
Journal: BMC complementary medicine and therapies
In common: sleep disorders, rat, cellular / molecular, 4 references
[2] doi:10.3389/fpsyg.2026.1821889
Gomisin E attenuates pentobarbital-induced sleep deficits in aging-related insomnia: an <i>in vivo</i> and <i>in silico</i> study implicating cholinergic signaling.
Journal: Frontiers in psychology
In common: NCBI GEO GSE208668, sleep disorders, rat, cellular / molecular, 1 reference
[3] doi:10.3390/ijms26051842
The Extract of <i>Piper nigrum</i> Improves the Cognitive Impairment and Mood in Sleep-Deprived Mice Through the JAK1/STAT3 Signalling Pathway.
Journal: International journal of molecular sciences
In common: NCBI GEO GSE208668, rat, cellular / molecular
[4] doi:10.3389/fmicb.2025.1541958
Effect of acupuncture at Back-Shu points on gut microbiota in insomnia model rats based on metagenomic sequencing technology.
Journal: Frontiers in microbiology
In common: sleep disorders, rat, cellular / molecular, 2 references
[5] doi:10.1186/s12888-026-08304-6
Transcranial direct current stimulation improves reduced global BOLD-CSF coupling in patients with insomnia disorder and comorbid anxiety: a resting-state functional MRI study.
Journal: BMC psychiatry
In common: sleep disorders, 2 references
[6] doi:10.3390/ph17091161
Beta-Myrcene as a Sedative-Hypnotic Component from Lavender Essential Oil in DL-4-Chlorophenylalanine-Induced-Insomnia Mice.
Journal: Pharmaceuticals (Basel, Switzerland)
In common: sleep disorders, cellular / molecular, 1 reference
[7] doi:10.1038/s41398-026-03895-w
Time-Dynamic analysis of sex-specific NREM sleep disturbance induced by social isolation among adolescent mice.
Journal: Translational psychiatry
In common: sleep disorders, 1 reference
[8] doi:10.3389/fmicb.2025.1645190
Zhi-zi-chi decoction exerts hypnotic effect through gut-brain axis modulation in insomnia mice.
Journal: Frontiers in microbiology
In common: sleep disorders, 1 reference
[9] doi:10.5498/wjp.v15.i4.104042
Digital cognitive behavioral therapy as a novel treatment for insomnia.
Journal: World journal of psychiatry
In common: sleep disorders, 1 reference
[10] doi:10.3389/fnmol.2026.1750882
Exploring the molecular mechanism of dexmedetomidine in alleviating blood-brain barrier disruption in rats with cerebral ischemia reperfusion injury based on network pharmacology.
Journal: Frontiers in molecular neuroscience
In common: rat, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.